查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1806191

小鼠模型市場（按模型類型、應用程式和最終用戶）—2025-2030 年全球預測

Mice Model Market by Model Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計小鼠模型市場規模在 2024 年將達到 16.1 億美元，2025 年將達到 17.4 億美元，2030 年將達到 26.1 億美元，複合年成長率為 8.38%。

主要市場統計數據
基準年2024年 16.1億美元
預計2025年 17.4億美元
預測年份 2030 26.1億美元
複合年成長率（%） 8.38%

探討創新小鼠系統如何演變成為現代臨床前研究架構中的重要資產

生物醫學研究的進步已將小鼠系統從簡單的實驗樣本提升為支持現代治療發現的複雜平台。過去十年，研究人員利用小鼠的遺傳可塑性和生理相關性，以更高的保真度模擬人類疾病。因此，這些模型已成為闡明分子路徑、檢驗藥物標靶和評估安全性的重要工具。

基因組編輯和人工智慧驅動的表現型分析的突破如何重新定義臨床前研究範式

基因組編輯技術的突破、對翻譯精準度的需求以及減少使用高階哺乳動物的倫理壓力，正在顯著改變小鼠模型研究的模式。 CRISPR-Cas9 及相關基因編輯平台使客製化敲除和人源化模型的創建普及，加快了研究進度並降低了成本。這些平台如今與先進的育種策略共存，以培育能夠重現複雜人類疾病特徵的基因工程小鼠。

因應2025年美國貿易措施的影響及其對模型採購和企業韌性的重大影響

2025年美國關稅的實施與升級，為小鼠模型生態系統帶來了挑戰和重新調整的機會。對進口科學耗材和專有種畜徵收的關稅增加了模型生產的成本，迫使許多機構重新評估其供應鏈和供應商組合。研究機構和委外研發機構正在尋求透過整合訂單、談判長期供應協議以及投資本地育種設施來減輕財務負擔。

我們揭示了模型類型複雜性和應用主導需求如何整合以形成不同的研究路徑

多樣化的研究需求和資金籌措重點推動小鼠模型市場細分為與特定實驗需求相符的不同類別。近交系小鼠品系提供可重複的遺傳背景，非常適合基礎研究；而遠交系小鼠則引入了反映人類群體特徵的異質性，並支持毒理學評估。在基因操作方面，條件性敲除可提供時間和組織特異性的控制；基因改造係表達外源基因用於通路分析；敲除模型透過完全基因消融闡明基因功能；人源化系統則重現人類免疫動力學。

評估推動小鼠研究平台差異化採用的區域研究生態系統和資金籌措重點

區域動態揭示了美洲、歐洲、中東和非洲以及亞太地區在研究投資、基礎設施和合作網路方面的微妙模式。在美洲，強大的資金生態系統和集中的生物技術中心促進了垂直整合的供應鏈，從而推動了先進小鼠模型的快速應用。北美研究聯盟和政府舉措促進了官民合作關係關係，從而加速了技術轉移。

繪製由技術領導和策略聯盟定義的競爭領導生態系統，推動小鼠模型創新

競爭格局涵蓋專業實驗動物設施營運商、基因工程先驅以及全方位服務供應商，這些供應商憑藉技術整合、產品組合廣度和全球影響力脫穎而出。領先的實驗動物供應商正在擴展其基因庫，涵蓋稀有基因敲除和人源化品系，並輔以合約育種服務，提供快速擴展和客製化的群體管理。

概述相關人員增強韌性和加速臨床前模型創新的策略方向

產業領導者應優先投資本地化育種基礎設施，以降低貿易相關風險並確保持續供應。建立具有可擴展能力的區域動物育種中心可以縮短前置作業時間，提高對緊急研究計劃的應對力，同時，促進與基因組編輯專家的合作，可以簡化與治療方案中的獨特靶點相匹配的客製化模型的開發。

詳細了解我們強大的混合研究框架，利用初步研究和全面的次要資料檢驗

我們的分析整合了多層次的調查方法，包括一手和二手資料收集、嚴格的檢驗和三角測量。首先，我們查閱了二級資訊來源，包括同行評審文獻、專利資料庫、監管文件和行業資料庫，以建立基本背景並識別新興趨勢。

整合洞察力、協作創新和策略遠見，塑造小鼠研究模型的未來

小鼠模型融合了科學創新、倫理考量和商業性需求。基因組編輯、數位表現型分析和區域投資策略等不斷發展的領域，凸顯出一個瞬息萬變的市場，其特徵是創造性與機會。積極應對供應鏈漏洞並擁抱新興技術的相關人員將佔據有利地位，引領下一波臨床前突破。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 擴展人源化小鼠模型以提高免疫腫瘤學的治療測試和轉化準確性
  • 利用3D生物列印小鼠類器官增強臨床前藥物安全性與毒性研究
  • 開發微生物組工程小鼠模型來研究神經退化研究中的腸腦軸相互作用
  • 在心血管研究中，對能夠更好地反映老年疾病表現型的老年小鼠模型的需求日益成長。
  • 利用高通量表現型分析平台進行精準醫療中的大規模小鼠基因篩檢
  • 將人工智慧驅動的影像分析整合到小鼠行為測試中，用於神經精神藥物的發現
  • 開發高度靈活的基因改造和基因敲除小鼠品系客製化育種計劃，以滿足專門的研究需求

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第 8 章 小鼠模型市場（依模型類型）

  • 基因工程小鼠模型
    • 條件敲除模型
    • 人源化小鼠模型
    • 基因敲除模型
    • 基因改造模型
  • 近交系小鼠模型
  • 雜交小鼠模型

第9章 小鼠模型市場（依應用）

  • 行為研究
  • 心血管疾病
  • 藥物研發與毒理學
  • 遺傳性疾病研究
  • 免疫學
  • 感染疾病
  • 代謝紊亂
  • 神經病學和神經退化性疾病
  • 腫瘤學研究

第 10 章 小鼠模型市場（依最終用戶）

  • 學術研究機構
  • 受託研究機構（CRO）
  • 醫院和診斷中心
  • 製藥和生物技術公司

第 11 章：美洲小鼠模型市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

12.歐洲、中東和非洲小鼠模型市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

13. 亞太地區小鼠模型市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Applied StemCell, Inc.
    • Aragen Life Sciences Ltd.
    • Biocytogen Boston Corporation
    • Charles River Laboratories International, Inc.
    • Creative Biolabs
    • Crown Bioscience by JSR Life Sciences, LLC
    • Cyagen US Inc. by PolyGene AG
    • Envigo by Inotiv, Inc.
    • GenOway
    • Harbour BioMed
    • inGenious Targeting Laboratory, Inc.
    • Janvier Labs
    • Marshall BioResources
    • MD Biosciences
    • Mirimus, Inc.
    • Ozgene Pty Ltd.
    • PhoenixBio Co., Ltd.
    • Shanghai Model Organisms Center, Inc.
    • Taconic Biosciences, Inc.
    • The Jackson Laboratory
    • TransCure bioServices
    • Translational Drug Development, LLC
    • Urosphere SAS
    • XenOPAT SL by Bellvitge Biomedical Research Institute

第15章 研究人工智慧

第16章 研究統計

第17章 研究聯絡人

第18章 研究報導

第19章 附錄

Product Code: MRR-4316E4E89369

The Mice Model Market was valued at USD 1.61 billion in 2024 and is projected to grow to USD 1.74 billion in 2025, with a CAGR of 8.38%, reaching USD 2.61 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.61 billion
Estimated Year [2025] USD 1.74 billion
Forecast Year [2030] USD 2.61 billion
CAGR (%) 8.38%

Exploring how innovative murine systems have evolved to become indispensable assets in contemporary preclinical research frameworks

Advancements in biomedical research have elevated the role of murine systems from simple laboratory specimens to sophisticated platforms that underpin modern therapeutic discovery. Over the past decade, researchers have harnessed the genetic malleability and physiological relevance of mice to model human diseases with ever-increasing fidelity. As a result, these models have become indispensable tools for elucidating molecular pathways, validating drug targets, and assessing safety profiles.

In parallel, the proliferation of novel genetic engineering technologies has expanded the repertoire of available strains, enabling conditional gene expression, humanized immune responses, and tissue-specific knockouts. This convergence of technical innovation and unmet clinical needs has accelerated preclinical workflows, reshaping research priorities across academia, industry, and clinical settings. Consequently, an understanding of the current mice model landscape is essential for stakeholders seeking to navigate competitive pressures and align their research strategies with emergent trends.

How breakthroughs in genome editing and AI-powered phenotyping are redefining the preclinical research paradigm

The landscape of mice model research is undergoing transformative shifts driven by breakthroughs in genome editing, demand for translational accuracy, and ethical pressures to reduce higher-order mammalian use. CRISPR-Cas9 and related gene-editing platforms have democratized the creation of custom knockouts and humanized models, accelerating timelines and lowering costs. These platforms now coexist with advanced breeding strategies to yield genetically engineered mice that replicate complex human disease signatures.

Meanwhile, the integration of high-throughput phenotyping and in vivo imaging has enhanced the resolution at which researchers monitor disease progression and therapeutic efficacy. Artificial intelligence and machine learning algorithms have begun to sift through enormous data sets generated in these studies, offering predictive insights and facilitating the selection of optimal model types.

Ethical considerations and regulatory scrutiny have further influenced the market, prompting the implementation of rigorous welfare standards and incentivizing the development of alternative assays. As stakeholders navigate these dynamic forces, they must remain agile to leverage innovations that improve translational relevance and operational efficiency.

Navigating the ramifications of US trade measures in 2025 and their profound implications on model sourcing and operational resilience

The introduction and escalation of United States tariffs in 2025 have introduced both challenges and recalibration opportunities for the mice model ecosystem. Tariffs on imported scientific consumables and proprietary breeding stock have elevated costs for model generation, compelling many organizations to reassess their supply chains and vendor portfolios. Research institutions and Contract Research Organizations have sought to mitigate financial burdens by consolidating orders, negotiating long-term supply agreements, and investing in localized breeding facilities.

Despite these headwinds, the tariff environment has also galvanized domestic production capacity, as vendors expand in-country vivaria and streamline licensing processes to meet shifting demand. Consequently, collaborative networks have emerged between academic centers and biotechnology firms to share breeding resources and expertise, fostering resilience against trade uncertainties. Companies that adapt by diversifying sourcing strategies and embracing vertical integration stand to enhance supply security while maintaining rigorous standards of reproducibility.

Uncovering how model type intricacies and application-driven requirements converge to shape distinct research pathways

Diverse research imperatives and funding priorities have driven the segmentation of the mice model market into distinct categories that align with specific experimental needs. Inbred mice strains provide reproducible genetic backgrounds ideal for foundational studies, while outbred models introduce heterogeneity that mirrors human populations and supports toxicology assessments. On the genetically engineered front, conditional knockouts offer temporal and tissue-specific control, transgenic lines express exogenous genes for pathway analysis, knockout models elucidate gene function through full gene removal, and humanized systems recapitulate human immune dynamics.

Application segmentation reveals a broad spectrum of disease and therapeutic domains. Behavioral studies leverage specialized strains to probe neurological function, whereas cardiovascular research benefits from hypertensive and atherosclerotic models. Drug discovery and toxicology demand robust systems for early safety screening, and genetic disease research relies on congenital and metabolic disorder models. Immunology experiments are underpinned by humanized mice, infectious disease research exploits susceptibility variants, neurodegenerative inquiries utilize Alzheimer's and Parkinson's transgenics, and oncology investigations draw upon xenograft and syngeneic tumor systems.

End users range from academic and research institutions driving fundamental science to contract research organizations performing outsourced studies. Hospitals and diagnostic centers integrate preclinical findings into translational initiatives, while pharmaceutical and biotechnology companies depend on these models to advance pipelines from candidate identification through pre-IND safety assessment. Each segment presents unique requirements, procurement cycles, and validation standards that inform tailored service offerings.

Evaluating regional research ecosystems and funding priorities that drive differentiated adoption of murine research platforms

Regional dynamics reveal nuanced patterns in research investment, infrastructure, and collaborative networks across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, robust funding ecosystems and concentrated biotechnology hubs have cultivated vertically integrated supply chains, enabling rapid adoption of advanced mouse models. North American research consortia and government initiatives foster public-private partnerships that accelerate technology translation.

Across Europe, Middle East & Africa, stringent regulatory frameworks have elevated animal welfare standards, prompting synchronized adoption of refinement techniques and alternative validation methods. Strong academic clusters in Western Europe collaborate with biotech startups to co-develop bespoke strains, while emerging markets in the Middle East and Africa focus on capacity building and training to broaden regional expertise.

The Asia-Pacific region exhibits explosive growth fueled by rising research expenditure, expanding contract research organizations, and government incentives aimed at biotech innovation. China, Japan, and South Korea lead investment in state-of-the-art vivarium infrastructure, whereas Southeast Asian nations emphasize cross-border partnerships and talent development to meet escalating demand for translational models.

Mapping the competitive ecosystem defined by technological leadership and strategic alliances driving murine model innovation

The competitive landscape features specialized vivarium operators, genetic engineering pioneers, and comprehensive service providers that differentiate through technology integration, portfolio breadth, and global reach. Leading laboratory animal suppliers have expanded their genetic archives to encompass rare knockout and humanized lines, complemented by contract breeding services that offer rapid scalability and customized colony management.

Innovators of genome-editing tools have forged partnerships with pharmaceutical giants to co-develop disease models aligned with pipeline priorities, while full-service contract research organizations bundle model provision with in vivo efficacy and toxicological evaluation. Strategic collaborations between academic institutions and commercial entities have accelerated the commercial deployment of new strains, deepening the bench-to-bedside integration.

Companies that invest in digital platforms for colony management and integrate imaging-based phenotyping services have gained a competitive edge by unlocking data-rich insights and fostering reproducibility. As intellectual property considerations intensify, players with robust patent portfolios and licensing frameworks command premium positioning, particularly for next-generation humanized and conditional knockout models.

Outlined strategic directives empowering stakeholders to enhance resilience and accelerate preclinical model innovation

Industry leaders should prioritize investments in localized breeding infrastructure to mitigate trade-related risks and ensure uninterrupted supply. Establishing regional vivarium hubs with scalable capacity will reduce lead times and enhance responsiveness to emergent research projects. Meanwhile, fostering collaborations with genome-editing specialists can streamline the development of bespoke models that match therapeutic pipelines' unique targets.

Organizations must also capitalize on digitalization by adopting cloud-based colony management systems and AI-driven phenotyping platforms. These tools not only bolster data integrity but also accelerate decision-making processes through predictive analytics. Concurrently, proactive engagement with regulatory authorities and ethics committees will help organizations anticipate evolving welfare standards and streamline model approval pathways.

Finally, corporate research divisions, academic centers, and contract organizations should coalesce around consortia that share best practices, breeding resources, and phenotypic databases. Such collaborative networks will dilute operational costs, spur innovation, and cultivate a resilient infrastructure capable of adapting to geopolitical and technological shifts.

Detailing a robust hybrid research framework leveraging primary interviews and comprehensive secondary data validation

Our analysis integrates a multi-layered research methodology composed of primary and secondary data collection, rigorous validation, and triangulation. Initially, secondary sources were examined, encompassing peer-reviewed literature, patent databases, regulatory filings, and industry white papers to establish foundational context and identify emerging trends.

Subsequently, in-depth interviews with key opinion leaders across academia, contract research organizations, and biotechnology firms provided qualitative insights into operational challenges, adoption drivers, and innovation roadblocks. Data gleaned from these discussions underwent cross-verification against commercial intelligence platforms, vendor catalogs, and technical specifications to ensure consistency.

Quantitative data points were subjected to triangulation through comparative analysis of company disclosures, public grant databases, and import-export records. This multi-pronged approach enabled a balanced perspective that accounts for both macro-level influences and micro-level decision criteria. Findings were then synthesized into coherent narratives that reflect current market realities, future inflection points, and actionable intelligence.

Synthesizing insights on collaborative innovation and strategic foresight shaping the future of murine research models

Mice models stand at the confluence of scientific innovation, ethical considerations, and commercial imperatives. The evolving landscape of genome editing, digital phenotyping, and regional investment strategies underscores a market in flux-one characterized by both disruption and opportunity. Stakeholders who proactively address supply-chain vulnerabilities and adopt emerging technologies will be well-positioned to lead the next wave of preclinical breakthroughs.

The cumulative impact of trade policies, shifting funding landscapes, and rising demand for translational fidelity necessitates an agile approach to portfolio planning and infrastructure development. By aligning operational capabilities with cutting-edge scientific advances and regulatory requirements, organizations can ensure sustained relevance and competitive differentiation.

In sum, the trajectory of mice model research hinges on collaboration, innovation, and strategic foresight. Those who master these imperatives will unlock new avenues for therapeutic discovery, augment their research efficiency, and ultimately contribute to meaningful advancements in human health.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Expansion of humanized mouse models to improve immuno-oncology therapeutic testing and translational accuracy
  • 5.2. Adoption of 3D bioprinted mouse organoids to enhance preclinical drug safety and toxicity studies
  • 5.3. Growth of microbiome-modified mouse models to investigate gut-brain axis interactions in neurodegenerative research
  • 5.4. Rising demand for aged mouse models to better mirror geriatric disease phenotypes in cardiovascular research
  • 5.5. Utilization of high-throughput phenotyping platforms for large-scale mouse genetic screening in precision medicine
  • 5.6. Integration of artificial intelligence-driven image analysis in mouse behavioral assays for neuropsychiatric drug discovery
  • 5.7. Development of ultra-flexible custom breeding programs for transgenic and knockout mouse lines to meet specialized research needs

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Mice Model Market, by Model Type

  • 8.1. Introduction
  • 8.2. Genetically Engineered Mice Models
    • 8.2.1. Conditional Knockout Models
    • 8.2.2. Humanized Mice Models
    • 8.2.3. Knockout Models
    • 8.2.4. Transgenic Models
  • 8.3. Inbred Mice Models
  • 8.4. Outbred Mice Models

9. Mice Model Market, by Application

  • 9.1. Introduction
  • 9.2. Behavioral Studies
  • 9.3. Cardiovascular Diseases
  • 9.4. Drug Discovery & Toxicology
  • 9.5. Genetic Disease Research
  • 9.6. Immunology
  • 9.7. Infectious Diseases
  • 9.8. Metabolic Disorders
  • 9.9. Neurology & Neurodegenerative Diseases
  • 9.10. Oncology Research

10. Mice Model Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutions
  • 10.3. Contract Research Organizations (CROs)
  • 10.4. Hospitals & Diagnostic Centers
  • 10.5. Pharmaceutical & Biotechnology Companies

11. Americas Mice Model Market

  • 11.1. Introduction
  • 11.2. United States
  • 11.3. Canada
  • 11.4. Mexico
  • 11.5. Brazil
  • 11.6. Argentina

12. Europe, Middle East & Africa Mice Model Market

  • 12.1. Introduction
  • 12.2. United Kingdom
  • 12.3. Germany
  • 12.4. France
  • 12.5. Russia
  • 12.6. Italy
  • 12.7. Spain
  • 12.8. United Arab Emirates
  • 12.9. Saudi Arabia
  • 12.10. South Africa
  • 12.11. Denmark
  • 12.12. Netherlands
  • 12.13. Qatar
  • 12.14. Finland
  • 12.15. Sweden
  • 12.16. Nigeria
  • 12.17. Egypt
  • 12.18. Turkey
  • 12.19. Israel
  • 12.20. Norway
  • 12.21. Poland
  • 12.22. Switzerland

13. Asia-Pacific Mice Model Market

  • 13.1. Introduction
  • 13.2. China
  • 13.3. India
  • 13.4. Japan
  • 13.5. Australia
  • 13.6. South Korea
  • 13.7. Indonesia
  • 13.8. Thailand
  • 13.9. Philippines
  • 13.10. Malaysia
  • 13.11. Singapore
  • 13.12. Vietnam
  • 13.13. Taiwan

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Applied StemCell, Inc.
    • 14.3.2. Aragen Life Sciences Ltd.
    • 14.3.3. Biocytogen Boston Corporation
    • 14.3.4. Charles River Laboratories International, Inc.
    • 14.3.5. Creative Biolabs
    • 14.3.6. Crown Bioscience by JSR Life Sciences, LLC
    • 14.3.7. Cyagen US Inc. by PolyGene AG
    • 14.3.8. Envigo by Inotiv, Inc.
    • 14.3.9. GenOway
    • 14.3.10. Harbour BioMed
    • 14.3.11. inGenious Targeting Laboratory, Inc.
    • 14.3.12. Janvier Labs
    • 14.3.13. Marshall BioResources
    • 14.3.14. MD Biosciences
    • 14.3.15. Mirimus, Inc.
    • 14.3.16. Ozgene Pty Ltd.
    • 14.3.17. PhoenixBio Co., Ltd.
    • 14.3.18. Shanghai Model Organisms Center, Inc.
    • 14.3.19. Taconic Biosciences, Inc.
    • 14.3.20. The Jackson Laboratory
    • 14.3.21. TransCure bioServices
    • 14.3.22. Translational Drug Development, LLC
    • 14.3.23. Urosphere SAS
    • 14.3.24. XenOPAT SL by Bellvitge Biomedical Research Institute

15. ResearchAI

16. ResearchStatistics

17. ResearchContacts

18. ResearchArticles

19. Appendix

LIST OF FIGURES

  • FIGURE 1. MICE MODEL MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL MICE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL MICE MODEL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL MICE MODEL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 12. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 14. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. MICE MODEL MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 20. MICE MODEL MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 21. MICE MODEL MARKET: RESEARCHAI
  • FIGURE 22. MICE MODEL MARKET: RESEARCHSTATISTICS
  • FIGURE 23. MICE MODEL MARKET: RESEARCHCONTACTS
  • FIGURE 24. MICE MODEL MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. MICE MODEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MICE MODEL MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MICE MODEL MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL MICE MODEL MARKET SIZE, BY CONDITIONAL KNOCKOUT MODELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MICE MODEL MARKET SIZE, BY CONDITIONAL KNOCKOUT MODELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL MICE MODEL MARKET SIZE, BY HUMANIZED MICE MODELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MICE MODEL MARKET SIZE, BY HUMANIZED MICE MODELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL MICE MODEL MARKET SIZE, BY KNOCKOUT MODELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MICE MODEL MARKET SIZE, BY KNOCKOUT MODELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL MICE MODEL MARKET SIZE, BY TRANSGENIC MODELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MICE MODEL MARKET SIZE, BY TRANSGENIC MODELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL MICE MODEL MARKET SIZE, BY INBRED MICE MODELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MICE MODEL MARKET SIZE, BY INBRED MICE MODELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL MICE MODEL MARKET SIZE, BY OUTBRED MICE MODELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MICE MODEL MARKET SIZE, BY OUTBRED MICE MODELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL MICE MODEL MARKET SIZE, BY BEHAVIORAL STUDIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MICE MODEL MARKET SIZE, BY BEHAVIORAL STUDIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL MICE MODEL MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MICE MODEL MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL MICE MODEL MARKET SIZE, BY DRUG DISCOVERY & TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MICE MODEL MARKET SIZE, BY DRUG DISCOVERY & TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL MICE MODEL MARKET SIZE, BY GENETIC DISEASE RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MICE MODEL MARKET SIZE, BY GENETIC DISEASE RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL MICE MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MICE MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL MICE MODEL MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MICE MODEL MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL MICE MODEL MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MICE MODEL MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL MICE MODEL MARKET SIZE, BY NEUROLOGY & NEURODEGENERATIVE DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MICE MODEL MARKET SIZE, BY NEUROLOGY & NEURODEGENERATIVE DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL MICE MODEL MARKET SIZE, BY ONCOLOGY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MICE MODEL MARKET SIZE, BY ONCOLOGY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL MICE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MICE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL MICE MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MICE MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL MICE MODEL MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MICE MODEL MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL MICE MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MICE MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. AMERICAS MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 58. AMERICAS MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 59. AMERICAS MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 60. AMERICAS MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 61. AMERICAS MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 62. AMERICAS MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 63. AMERICAS MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 64. AMERICAS MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 67. UNITED STATES MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. UNITED STATES MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 69. UNITED STATES MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 70. UNITED STATES MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 71. UNITED STATES MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. UNITED STATES MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 73. UNITED STATES MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 74. UNITED STATES MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 75. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 76. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 77. CANADA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. CANADA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 79. CANADA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 80. CANADA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 81. CANADA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. CANADA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 83. CANADA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 84. CANADA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 85. MEXICO MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 86. MEXICO MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 87. MEXICO MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 88. MEXICO MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 89. MEXICO MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 90. MEXICO MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 91. MEXICO MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 92. MEXICO MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 93. BRAZIL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. BRAZIL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 95. BRAZIL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 96. BRAZIL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 97. BRAZIL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 98. BRAZIL MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 99. BRAZIL MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 100. BRAZIL MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 101. ARGENTINA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. ARGENTINA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. ARGENTINA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 104. ARGENTINA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 105. ARGENTINA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. ARGENTINA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 107. ARGENTINA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. ARGENTINA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED KINGDOM MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED KINGDOM MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED KINGDOM MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED KINGDOM MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED KINGDOM MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED KINGDOM MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED KINGDOM MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED KINGDOM MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 127. GERMANY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. GERMANY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. GERMANY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 130. GERMANY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 131. GERMANY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. GERMANY MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 133. GERMANY MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GERMANY MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. FRANCE MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. FRANCE MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 137. FRANCE MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 138. FRANCE MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 139. FRANCE MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. FRANCE MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 141. FRANCE MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. FRANCE MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 143. RUSSIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. RUSSIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 145. RUSSIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 146. RUSSIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 147. RUSSIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. RUSSIA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 149. RUSSIA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. RUSSIA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 151. ITALY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. ITALY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 153. ITALY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 154. ITALY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 155. ITALY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. ITALY MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 157. ITALY MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. ITALY MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 159. SPAIN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. SPAIN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 161. SPAIN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 162. SPAIN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 163. SPAIN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. SPAIN MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 165. SPAIN MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. SPAIN MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 175. SAUDI ARABIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. SAUDI ARABIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 177. SAUDI ARABIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 178. SAUDI ARABIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 179. SAUDI ARABIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. SAUDI ARABIA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 181. SAUDI ARABIA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. SAUDI ARABIA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 183. SOUTH AFRICA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. SOUTH AFRICA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. SOUTH AFRICA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 186. SOUTH AFRICA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 187. SOUTH AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. SOUTH AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 189. SOUTH AFRICA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. SOUTH AFRICA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 191. DENMARK MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. DENMARK MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. DENMARK MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 194. DENMARK MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 195. DENMARK MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. DENMARK MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 197. DENMARK MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. DENMARK MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. NETHERLANDS MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 202. NETHERLANDS MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. NETHERLANDS MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. NETHERLANDS MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 207. QATAR MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. QATAR MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 209. QATAR MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 210. QATAR MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 211. QATAR MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. QATAR MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 213. QATAR MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. QATAR MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 215. FINLAND MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. FINLAND MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 217. FINLAND MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 218. FINLAND MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 219. FINLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. FINLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 221. FINLAND MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. FINLAND MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 223. SWEDEN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. SWEDEN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 225. SWEDEN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 226. SWEDEN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 227. SWEDEN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. SWEDEN MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 229. SWEDEN MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. SWEDEN MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 231. NIGERIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. NIGERIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. NIGERIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 234. NIGERIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 235. NIGERIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. NIGERIA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 237. NIGERIA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. NIGERIA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 239. EGYPT MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. EGYPT MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 241. EGYPT MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 242. EGYPT MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 243. EGYPT MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EGYPT MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 245. EGYPT MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EGYPT MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 247. TURKEY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. TURKEY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. TURKEY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 250. TURKEY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 251. TURKEY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. TURKEY MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. TURKEY MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. TURKEY MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 255. ISRAEL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ISRAEL MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 257. ISRAEL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 258. ISRAEL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 259. ISRAEL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. ISRAEL MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 261. ISRAEL MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ISRAEL MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 263. NORWAY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. NORWAY MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. NORWAY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 266. NORWAY MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 267. NORWAY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NORWAY MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 269. NORWAY MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. NORWAY MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 271. POLAND MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. POLAND MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. POLAND MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 274. POLAND MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 275. POLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. POLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 277. POLAND MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. POLAND MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 279. SWITZERLAND MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. SWITZERLAND MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 281. SWITZERLAND MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 282. SWITZERLAND MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 283. SWITZERLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. SWITZERLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 285. SWITZERLAND MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. SWITZERLAND MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 297. CHINA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. CHINA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 299. CHINA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 300. CHINA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 301. CHINA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. CHINA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 303. CHINA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. CHINA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 305. INDIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. INDIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 307. INDIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 308. INDIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 309. INDIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. INDIA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 311. INDIA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. INDIA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 313. JAPAN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. JAPAN MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 315. JAPAN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 316. JAPAN MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 317. JAPAN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. JAPAN MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 319. JAPAN MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. JAPAN MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 321. AUSTRALIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. AUSTRALIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 323. AUSTRALIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 324. AUSTRALIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 325. AUSTRALIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. AUSTRALIA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 327. AUSTRALIA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. AUSTRALIA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 329. SOUTH KOREA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. SOUTH KOREA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 331. SOUTH KOREA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 332. SOUTH KOREA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 333. SOUTH KOREA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. SOUTH KOREA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 335. SOUTH KOREA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. SOUTH KOREA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 337. INDONESIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. INDONESIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 339. INDONESIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 340. INDONESIA MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 341. INDONESIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. INDONESIA MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 343. INDONESIA MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 344. INDONESIA MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 345. THAILAND MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. THAILAND MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 347. THAILAND MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 348. THAILAND MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 349. THAILAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 350. THAILAND MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 351. THAILAND MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 352. THAILAND MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 353. PHILIPPINES MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 354. PHILIPPINES MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 355. PHILIPPINES MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2018-2024 (USD MILLION)
  • TABLE 356. PHILIPPINES MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE MODELS, 2025-2030 (USD MILLION)
  • TABLE 357. PHILIPPINES MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 358. PHILIPPINES MICE MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 359. PHILIPPINES MICE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 360. PHILIPPINES MICE MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 361. MALAYSIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 362. MALAYSIA MICE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
  • TABLE 363. MALAYSIA MICE MODEL MARKET SIZE, B